About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

Iran’s UN ambassador in Geneva said that, ahead of talks on the nuclear file and the IAEA’s role, all five sections of the memorandum of understanding must be fully implemented.

2026-06-23

Iran’s UN ambassador in Geneva said that, ahead of talks on the nuclear file and the IAEA’s role, all five sections of the memorandum of understanding must be fully implemented.

Other News
2026-06-23

A U.S. official told CNN on Monday that Washington has established a monitoring mechanism for the fragile Lebanon ceasefire after repeated violations by Israel and Hezbollah that risked US‑Iran talks. The official said Secretary of State Rubio phoned

A U.S. official told CNN on Monday that Washington has established a monitoring mechanism for the fragile Lebanon ceasefire after repeated violations by Israel and Hezbollah that risked US‑Iran talks. The official said Secretary of State Rubio phoned Israeli Prime Minister Netanyahu and Lebanese President Aoun last Friday to discuss consolidating the ceasefire and future negotiations. Following those calls, U.S. Central Command launched the monitoring mechanism to give policymakers real‑time, accurate visibility of fighting inside Lebanon. It was unclear whether this is the same as the “conflict‑avoidance mechanism” Vice President Vance said had been set up on Sunday afternoon Swiss time.
2026-06-23

Sinovac Biotech’s fully human anti-tetanus monoclonal antibody SNA02-48 injection has entered a Phase III trial, with the first volunteer enrolled at Shenzhen Second People’s Hospital. SNA02-48 was cleared for clinical use in March 2025 and is a reco

Sinovac Biotech’s fully human anti-tetanus monoclonal antibody SNA02-48 injection has entered a Phase III trial, with the first volunteer enrolled at Shenzhen Second People’s Hospital. SNA02-48 was cleared for clinical use in March 2025 and is a recombinant fully human mAb for emergency post-exposure prophylaxis against tetanus. Sinovac is expanding a wound-care portfolio covering active and passive immunity: its adsorbed tetanus vaccine is market-approved; Sinovac-backed Xingmeng Biotech’s Class 1 innovative drug Krebi® (monoclonal antibody injection) is approved for passive immunization of adults exposed to rabies; Sinovac’s lyophilized human rabies vaccine (serum-free Vero cell) is in the regulatory filing stage.
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.